Aries launches Eleview injectable for GI endoscopy: 4 key notes

Aries Pharmaceuticals launched its submucosal injectable composition Eleview.

Advertisement

Here’s what you should know.

1. Eleview allows providers to remove polyps, adenomas, early stage cancers and other lesions in the gastrointestinal tract.

2. Cosmo Pharmaceuticals developed Eleview. Aries is the product’s sole U.S. distributor.

3. Eleview creates a cushion that gives gastroenterologists improved lesion visibility and helps physicians remove lesions.

4. Researchers compared Eleview to saline, a commonly used agent. The study states that Eleview “demonstrated better cushion-forming ability and a duration of lift of up to 45 minutes.”

More articles on gastroenterology:
7 things to know about gastroenterologist job satisfaction
Analysts weigh in on Allergan Q1 EPS & more — 4 updates on GI companies
GI leader to know: Dr. Ananya Das of the Arizona Center for Digestive Health

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.